Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells

Ming Fang Cheng, Chian Her Lee, Guo Shu Huang, Huang Wei Wu, Pei Chun Chiang, Lai Fa Sheu, Herng Sheng Lee

Research output: Contribution to journalArticle

Abstract

Background: The objective of this study was to investigate the expression of β-arrestin 2 in G292 fibroblast-like phenotype osteosarcoma cells after stimulation with oncostatin M, a gp130-type multifunctional cytokine of the interleukin-6 family. Methods: The changes in β-arrestin 2 mRNA levels in G292 cells following staurosporine and oncostatin M treatments were analyzed by RT-PCR. The signal transduction pathways including MAP 44/42 and signal transducer and activator of transcription (STAT) were also evaluated by western blotting. Growth inhibition of tumor cells after treatment with oncostatin M was also assessed by tetrazolium (MTT) assay. Results: The level of β-arrestin 2 mRNA in these cells was upregulated in a time- and dose-dependent manner. Levels of β-arrestin 2 mRNA were increased 1.22- and 1.74-fold after 12 and 24 h of treatment with 10 ng/ml oncostatin M (P <0.05), and 100 ng/ ml of oncostatin M induced even higher levels of β-arrestin 2 mRNA. Increased phosphorylation of MAP 44/42 and STAT3(Ser 727) were also noted, without alteration in the phosphorylation of STAT1(Ser 727), STAT3(Thr 705), STAT5(Tyr 694) or STAT6(Tyr 641). Growth inhibition of the tumor cells was also revealed by a 17.2% decrease in cell number after 24 h incubation. Conclusions: The data indicated that oncostatin M might reduce growth rate of osteosarcoma cells by upregulation of β-affestin 2 and the activation of MAP44/42 and STAT3(Ser 727). The findings provide useful information for elucidating the mechanism of oncostatin M-mediated growth inhibition in osteosarcoma cells.

Original languageEnglish
Pages (from-to)13-18
Number of pages6
JournalJournal of Medical Sciences (Taiwan)
Volume29
Issue number1
Publication statusPublished - Feb 2009
Externally publishedYes

Fingerprint

Oncostatin M
Osteosarcoma
Up-Regulation
Growth
Messenger RNA
Phosphorylation
Staurosporine
beta-Arrestin 1
Transducers
Interleukin-6
Signal Transduction
Neoplasms
Fibroblasts
Cell Count
Western Blotting
Cytokines
Phenotype
Polymerase Chain Reaction

Keywords

  • β-arrestin
  • Oncostatin M
  • Osteosarcoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cheng, M. F., Lee, C. H., Huang, G. S., Wu, H. W., Chiang, P. C., Sheu, L. F., & Lee, H. S. (2009). Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells. Journal of Medical Sciences (Taiwan), 29(1), 13-18.

Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells. / Cheng, Ming Fang; Lee, Chian Her; Huang, Guo Shu; Wu, Huang Wei; Chiang, Pei Chun; Sheu, Lai Fa; Lee, Herng Sheng.

In: Journal of Medical Sciences (Taiwan), Vol. 29, No. 1, 02.2009, p. 13-18.

Research output: Contribution to journalArticle

Cheng, MF, Lee, CH, Huang, GS, Wu, HW, Chiang, PC, Sheu, LF & Lee, HS 2009, 'Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells', Journal of Medical Sciences (Taiwan), vol. 29, no. 1, pp. 13-18.
Cheng, Ming Fang ; Lee, Chian Her ; Huang, Guo Shu ; Wu, Huang Wei ; Chiang, Pei Chun ; Sheu, Lai Fa ; Lee, Herng Sheng. / Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells. In: Journal of Medical Sciences (Taiwan). 2009 ; Vol. 29, No. 1. pp. 13-18.
@article{27314ef6a75e4536a4e869602e1c93e0,
title = "Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells",
abstract = "Background: The objective of this study was to investigate the expression of β-arrestin 2 in G292 fibroblast-like phenotype osteosarcoma cells after stimulation with oncostatin M, a gp130-type multifunctional cytokine of the interleukin-6 family. Methods: The changes in β-arrestin 2 mRNA levels in G292 cells following staurosporine and oncostatin M treatments were analyzed by RT-PCR. The signal transduction pathways including MAP 44/42 and signal transducer and activator of transcription (STAT) were also evaluated by western blotting. Growth inhibition of tumor cells after treatment with oncostatin M was also assessed by tetrazolium (MTT) assay. Results: The level of β-arrestin 2 mRNA in these cells was upregulated in a time- and dose-dependent manner. Levels of β-arrestin 2 mRNA were increased 1.22- and 1.74-fold after 12 and 24 h of treatment with 10 ng/ml oncostatin M (P <0.05), and 100 ng/ ml of oncostatin M induced even higher levels of β-arrestin 2 mRNA. Increased phosphorylation of MAP 44/42 and STAT3(Ser 727) were also noted, without alteration in the phosphorylation of STAT1(Ser 727), STAT3(Thr 705), STAT5(Tyr 694) or STAT6(Tyr 641). Growth inhibition of the tumor cells was also revealed by a 17.2{\%} decrease in cell number after 24 h incubation. Conclusions: The data indicated that oncostatin M might reduce growth rate of osteosarcoma cells by upregulation of β-affestin 2 and the activation of MAP44/42 and STAT3(Ser 727). The findings provide useful information for elucidating the mechanism of oncostatin M-mediated growth inhibition in osteosarcoma cells.",
keywords = "β-arrestin, Oncostatin M, Osteosarcoma",
author = "Cheng, {Ming Fang} and Lee, {Chian Her} and Huang, {Guo Shu} and Wu, {Huang Wei} and Chiang, {Pei Chun} and Sheu, {Lai Fa} and Lee, {Herng Sheng}",
year = "2009",
month = "2",
language = "English",
volume = "29",
pages = "13--18",
journal = "Journal of Medical Sciences",
issn = "1011-4564",
publisher = "國防醫學院",
number = "1",

}

TY - JOUR

T1 - Oncostatin M induces upregulation of β-arrestin 2 and growth inhibition in osteosarcoma cells

AU - Cheng, Ming Fang

AU - Lee, Chian Her

AU - Huang, Guo Shu

AU - Wu, Huang Wei

AU - Chiang, Pei Chun

AU - Sheu, Lai Fa

AU - Lee, Herng Sheng

PY - 2009/2

Y1 - 2009/2

N2 - Background: The objective of this study was to investigate the expression of β-arrestin 2 in G292 fibroblast-like phenotype osteosarcoma cells after stimulation with oncostatin M, a gp130-type multifunctional cytokine of the interleukin-6 family. Methods: The changes in β-arrestin 2 mRNA levels in G292 cells following staurosporine and oncostatin M treatments were analyzed by RT-PCR. The signal transduction pathways including MAP 44/42 and signal transducer and activator of transcription (STAT) were also evaluated by western blotting. Growth inhibition of tumor cells after treatment with oncostatin M was also assessed by tetrazolium (MTT) assay. Results: The level of β-arrestin 2 mRNA in these cells was upregulated in a time- and dose-dependent manner. Levels of β-arrestin 2 mRNA were increased 1.22- and 1.74-fold after 12 and 24 h of treatment with 10 ng/ml oncostatin M (P <0.05), and 100 ng/ ml of oncostatin M induced even higher levels of β-arrestin 2 mRNA. Increased phosphorylation of MAP 44/42 and STAT3(Ser 727) were also noted, without alteration in the phosphorylation of STAT1(Ser 727), STAT3(Thr 705), STAT5(Tyr 694) or STAT6(Tyr 641). Growth inhibition of the tumor cells was also revealed by a 17.2% decrease in cell number after 24 h incubation. Conclusions: The data indicated that oncostatin M might reduce growth rate of osteosarcoma cells by upregulation of β-affestin 2 and the activation of MAP44/42 and STAT3(Ser 727). The findings provide useful information for elucidating the mechanism of oncostatin M-mediated growth inhibition in osteosarcoma cells.

AB - Background: The objective of this study was to investigate the expression of β-arrestin 2 in G292 fibroblast-like phenotype osteosarcoma cells after stimulation with oncostatin M, a gp130-type multifunctional cytokine of the interleukin-6 family. Methods: The changes in β-arrestin 2 mRNA levels in G292 cells following staurosporine and oncostatin M treatments were analyzed by RT-PCR. The signal transduction pathways including MAP 44/42 and signal transducer and activator of transcription (STAT) were also evaluated by western blotting. Growth inhibition of tumor cells after treatment with oncostatin M was also assessed by tetrazolium (MTT) assay. Results: The level of β-arrestin 2 mRNA in these cells was upregulated in a time- and dose-dependent manner. Levels of β-arrestin 2 mRNA were increased 1.22- and 1.74-fold after 12 and 24 h of treatment with 10 ng/ml oncostatin M (P <0.05), and 100 ng/ ml of oncostatin M induced even higher levels of β-arrestin 2 mRNA. Increased phosphorylation of MAP 44/42 and STAT3(Ser 727) were also noted, without alteration in the phosphorylation of STAT1(Ser 727), STAT3(Thr 705), STAT5(Tyr 694) or STAT6(Tyr 641). Growth inhibition of the tumor cells was also revealed by a 17.2% decrease in cell number after 24 h incubation. Conclusions: The data indicated that oncostatin M might reduce growth rate of osteosarcoma cells by upregulation of β-affestin 2 and the activation of MAP44/42 and STAT3(Ser 727). The findings provide useful information for elucidating the mechanism of oncostatin M-mediated growth inhibition in osteosarcoma cells.

KW - β-arrestin

KW - Oncostatin M

KW - Osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=61849185612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61849185612&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 13

EP - 18

JO - Journal of Medical Sciences

JF - Journal of Medical Sciences

SN - 1011-4564

IS - 1

ER -